Potential for three price sensitive announcements before Christmas -
- Home care agreement signed last week with an ASX listed provider to be announced Q4CY21 in joint ASX announcement - as per Sept quarterly update. I believe there is only one ASX aged care provider that currently offers home care...
- Painchek Infant announcement possibly with a global therapeutic pain medication partner this year - refer Kalkine presentation below, 1hr 4min mark - PD - "we have some exciting news about that which we will announce later this year"
- Disability Care - As per the quarterly update - Nulsen trial has concluded. PainChek to meet this month with key representatives of the Nulsen Group, and of Curtin University, to discuss in depth the outcomes achieved throughout the six-month trial, and next steps. Also reference Kalkine presentation, 1hr 14min mark - PD - "we've got some really interesting studies with disabilities because that's another area where there is a real struggle to assess pain and we should be announcing that pretty soon"
Could be a good Christmas.
- Forums
- ASX - By Stock
- PCK
- PainChek General Discussion
PainChek General Discussion, page-19567
-
- There are more pages in this discussion • 846 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $45.84M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $64.49K | 2.298M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 0.028 |
4 | 1287037 | 0.027 |
4 | 1040000 | 0.026 |
4 | 1159601 | 0.025 |
1 | 41252 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 65000 | 1 |
0.031 | 18000 | 1 |
0.032 | 89187 | 1 |
0.033 | 100000 | 1 |
0.034 | 108791 | 1 |
Last trade - 15.14pm 12/11/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online